To support the creation of this comprehensive clinical research program to address both neurodegenerative disorders and restoration of motor function after spinal cord injury. Research will focus on amyotrophic lateral sclerosis (ALS or Lou Gehrig’s disease), for which there currently is no treatment or cure, and spinal muscular atrophy (SMA), the leading genetic killer of infants and toddlers.
